| parent | Oncology drugs | LP31428-3 |
| child | Methotrexate.free | LP207771-9 |
| child | Methotrexate | Body fluid | Drug toxicology | LP390955-5 |
| child | Methotrexate | Cerebral spinal fluid | Drug toxicology | LP390956-3 |
| child | Methotrexate monoglutamate | LP212193-9 |
| child | Methotrexate diglutamate | LP212194-7 |
| child | Methotrexate | Serum or Plasma | Drug toxicology | LP390957-1 |
| child | Methotrexate | Urine | Drug toxicology | LP390958-9 |
| child | Methotrexate pentaglutamate | LP212197-0 |
| child | Methotrexate polyglutamates | LP188434-7 |
| child | Methotrexate tetraglutamate | LP212196-2 |
| child | Methotrexate triglutamate | LP212195-4 |
| parent | Oncology drugs | LP31428-3 |
| child | Methotrexate | Dose | Drug doses | LP392356-4 |
| STATUS | ACTIVE |
| PartDisplayName | en-US | Methotrexate |
| DisplayName | en-US | Methotrexate |
LOINC Version: 2.81
FHIR